Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c8bffd30b513a7c8ac7d736fa3ef27f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-08 |
filingDate |
1983-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1987-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e7ad4b68fa6b2299f685fe607b0477a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2a7ef47093c6d23d87ab6bf4749756c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_790abb8b392b73deee4d2aba1792b49b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3f528c87082a0080f37079400e083c6 |
publicationDate |
1987-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-1221983-A |
titleOfInvention |
Halogenophenyl glyceride esters |
abstract |
ABSTRACT OF THE DISCLOSURE HALOGENOPHENYL GLYCERIDE ESTERS The invention concerns novel glyceride esters of anti-bacterial halogenated phenols having the formula I in which Ra and Rb are independently (3-20C)alkyl or (3-20C)al-kenyl; Rc and Rd are independently chloro or bromo; Re is hydro-gen, chloro or bromo; and A is (1-6C)alkylene optionally bearing one or two (1-4C)alkyl substituents. The esters are of use in the prophylaxis and/or therapy of acne vulgaris. Pharmaceutical com-positions for topical administration and processes for the manu-facture of the esters are also provided. |
priorityDate |
1982-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |